Take a peek behind the scenes of a recently published study in the journal Nanomedicine as we ask first author, Filippo Rossi (Politecnico di Milano, Italy), about the challenges in moving nanovector-based therapies into the clinic for spinal cord injuries.
Take a look behind the scenes of a recent Review paper from Neurodegenerative Disease Management as we ask first author, Jiwon Oh (University of Toronto, Canada), about the diagnostic and management issues surrounding progressive multiple sclerosis.
In this research article from the Journal of Comparative Effectiveness Research, the authors assess the real-world outcomes among patients with Duchenne muscular dystrophy receiving deflazacort or prednisone in real-world practice.
This review article from the journal Pain Management provides a summary of national and international evidence-based guidelines for common pain conditions to guide primary healthcare practitioners on recommended non-prescription analgesic treatments.
In this interview from the Video Journal of Biomedicine, Hannah Brown (Ipsos Healthcare, London, UK) discusses physician and patient treatment decision-making for relapsing–remitting multiple sclerosis.
Take a look behind the scenes of a study published in Brain, as we ask Dr Ryan D’Arcy about the establishment of brain vital signs for concussion-related impairments.
Discover more about an ongoing, multicenter registry that provides real-world evidence regarding ataluren use in nonsense mutation Duchenne muscular dystrophy patients in this research article.
In this Editorial, published in the journal Future Neurology, the author discusses the need for continued funding for spinal muscular atrophy.
In this review article, published in the journal Immunotherapy, the authors explore immunotherapy for neuroblastoma from therapeutic backbone to the latest discoveries.
Take a look behind the scenes of a recent paper in Biomarkers in Medicine as we ask the author about oligomeric α-synuclein in basal tears of Parkinson’s patients.